Back to newsroom
News
Drug That Gives Pancreatic Cancer Patients More Time is Out of Reach

September 24, 2020

Image of RASONQUE (daraxonrasib) bottle and carton packaging.

Drug That Could Give Pancreatic Cancer Patients More Time is Out of Reach: Healthing.com

PCC CEO Michelle Capobianco, pancreatic cancer researchers and patient advocates question the pan-Canadian Pharmaceutical Alliance (pCPA) delaying the funding of pancreatic cancer treatment ONIVYDE, which was approved by Health Canada three years ago.Healthing FILE PHOTO: Justice Ruth Bader Ginsburg attends the lunch session of The Women's Conference in Long Beach, California October 26, 2010. REUTERS/Mario Anzuoni/File Photo ORG XMIT: FW1

Be part of the force driving answers for this devastating disease.

Make a donation towards pancreatic cancer research and support programs.

donate today

Keep in the loop:

Read more PCNA News:

discover more

Research
Six Months is a Start

Research
We Asked. You Shared. Here’s What We Do Next.

August 19, 2026

Research
It's Probably Just Menopause...